Modern Medicine Cases

ODs look to lid scrubs first for blepharitis treatmentIn a poll fielded on the Optometry Times website, we asked ODs what they used for first-line therapy for blepharitis patients.
6 challenges when changing from a group to private practice
6 challenges when changing from a group to private practiceA little over 18 months ago, I decided to follow my passion and take a leap of faith changing my career. I went from a bustling MD/OD group practice to a private group OD practice and launched the Dry Eye Center of Pennsylvania (PA).
Sustained-release corticosteroid implant improves, slows progression of diabetic retinopathySustained intraocular delivery of fluocinolone acetonide (FAc) using the FAc 0.19 mg intravitreal implant (Iluvien, Alimera Sciences) improves and slows progression of diabetic retinopathy (DR), according to findings of post-hoc analyses of data from the pivotal Fluocinolone Acetonide for Diabetic Macular Edema (FAME) trials.
Novel anti-VEGF-A agent shows promise for prolonged DME activityAbicipar pegol (Allergan/Molecular Partners) met its primary and key secondary endpoints and demonstrated an acceptable overall safety profile in a phase II trial investigating use of the novel anti-VEGF-A agent for treatment of diabetic macular edema (DME).
No sign of chloramphenicol resistance in bacterial conjunctivitisChloramphenicol remains effective against Gram-positive bacteria, the most common agent in bacterial conjunctivitis, researchers say.
5 ways to get the most out of an IT partner
5 ways to get the most out of an IT partnerWhile the widespread adoption of electronic health records (EHRs) among healthcare providers is here, the dramatic boost in efficiency across the healthcare system that was supposed to accompany this shift has yet to be fully realized.
5 things you missed at SECO 2017 in Atlanta
5 things you missed at SECO 2017 in AtlantaSECO 2017 has come to a close, but Optometry Times has you covered with things you may have missed while taking in a lecture, perusing the exhibit hall, or exploring Atlanta’s Centennial Park.
What Anthem-Cigna merger rejection means for your practice
What Anthem-Cigna merger rejection means for your practiceEarlier this month, federal judge Amy Berman Jackson of the U.S. District Court for the District of Columbia ruled against the proposed $54 billion merger between Anthem and Cigna, the second- and third-largest commercial health insurers in the country.
White men need to do their part and make healthcare safe again
White men need to do their part and make healthcare safe againYes, white women voted for Trump in large numbers as well, but, across the country, the Republican leadership primarily relies on the votes of white men. For now, this is the group that is most powerful when it steps up.
The key to understanding consumer-centric healthcareFor over a decade, we have seen the steady rise of consumerism in healthcare. Far more than an emerging trend, it is now something that will dramatically alter the U.S. healthcare delivery system...for the better.